In the literature, genetic variants around ERAP2 have been associated with autoimmunity related disorders, whereas the ZSCAN9 gene is surrounded by the risk variants for neuropsychiatric diseases and cancer (Figure 2A,B). This evidence concerns the gene ERAP2 and cancer.